Teva Pharma (TEVA) Raises Q2 Outlook

(Updated - July 12, 2016 4:07 PM EDT)

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will host a conference call and webcast for the investment community on Wednesday, July 13, 2016 at 8:00 a.m. ET to communicate its preliminary non-GAAP financial results for the quarter ended June 30, 2016. The Company will also provide its preliminary non-GAAP financial outlook for the years 2016 - 2019, which will include its pending acquisition of the Actavis Generics business that is awaiting FTC clearance.

On the conference call and webcast, the Company will communicate that it now expects revenues for the second quarter of 2016 to be $4.9 – $5.0 billion compared to its previous guidance of $4.8 – $4.9 billion, while non-GAAP EPS for the quarter is now expected to be $1.19 – $1.22 compared to the previous guided range of $1.16 – $1.20 based on a fully diluted weighted average number of shares of 980 million. Cash flow from operating activities is now expected to be $1.0 – $1.1 billion compared to $1.2 – $1.3 billion.

(Street sees Q2 EPS of $1.17 on revenue of $4.81 billion)

In order to participate, please dial the following numbers (at least 10 minutes before the scheduled start time): United States 1-866-254-0808; Canada 1-866-607-2172 or International +44(0) 1452-541003; passcode: 46404463. For a list of other international toll-free numbers, click here.

A live webcast of the call will also be available on Teva's website at: www.ir.tevapharm.com. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software.

Following the conclusion of the call, a replay of the webcast will be available within 24 hours on the Company's website. The replay can also be accessed until August 8, 2016, 9:00 a.m. ET by calling United States 1-866-247-4222; Canada 1-866-878-9237 or International +44(0) 1452-550000; passcode: 46404463.

You May Also Be Interested In

• Nanometrics (NANO) Issues Business Update, Reports FY23 Results
• Ford (F) earnings beat estimates in Q1, revenue falls short; stock up
• Splash Beverage Group Inc. (SBEV) Appoints Julius Ivancsits as CFO